Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04985019
Other study ID # 3-2018-0292
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 14, 2018
Est. completion date January 4, 2021

Study information

Verified date July 2021
Source Gangnam Severance Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether mobile-based virtual reality exposure treatement can reduce the symptoms of panic disorder and the symptoms of depression and anxiety than the waitlist group


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date January 4, 2021
Est. primary completion date January 4, 2021
Accepts healthy volunteers No
Gender All
Age group 19 Years to 60 Years
Eligibility Inclusion Criteria: - Meet Diagnostic Statistical Manual criteria for panic disorder(with or without agoraphobia) . No change in drug dosage during the study period Exclusion Criteria: - Patients with a history of major neurological or significant medical illness, or met the diagnostic criteria of current substance misuse

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Arm I (Prepectoral)
Participants followed the Self-Guided Virtual Reality-based Cognitive Behavioral Therapy for 4 weeks.
Other:
Arm II (Subpectoral)
Participants followed the Self-Guided Virtual Reality-based Cognitive Behavioral Therapy for 4 weeks.

Locations

Country Name City State
Korea, Republic of Gangnam Severance Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Gangnam Severance Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Panic Disorder Severity Scale The Panic Disorder Severity Scale consists of 7 items, each rated on a 5-point scale that assesses panic frequency, distress during panic, panic-focused anticipatory anxiety, phobic avoidance of situations, phobic avoidance of physical sensations, impairment in work functioning, and impairment in social functioning 4 weeks
Secondary The heart rate variability The heart rate variability is the physiological recordings of the variation in the time interval between consecutive heartbeats in milliseconds 4 weeks
Secondary The Hamilton Rating Scale for Depression The Hamilton Rating Scale for Depression is a depression assessment scale and contains 17 items pertaining to symptoms of depression experienced over the past week 4 weeks
Secondary The State and Trait Anxiety questionnaire The State and Trait Anxiety questionnaire is has 20 items for assessing trait anxiety and 20 for state anxiety 4 weeks
Secondary The Korean Inventory of Depressive Symptomatology The Korean Inventory of Depressive Symptomatology is a self-report questionnaire that comprises symptoms of depression including melancholic, atypical and anxious symptoms 4 weeks
Secondary The Perceived Stress Scale The Perceived Stress Scale is is a measure of the degree to which situations in one's life are appraised as stressful 4 weeks
Secondary The Albany Panic and Phobia Questionnaire The Albany Panic and Phobia Questionnaire is a 27-item 9-point Likert scale that was designed to measure the distinct dimension of fear in various situations, and has three subscales: social phobia, agoraphobia, and interoceptive fear 4 weeks
Secondary The Hospital Anxiety and Depression Scale The Hospital Anxiety and Depression Scale is a 14-item scale that has anxiety and depression subscales; 4 weeks
Secondary The Body Sensations Questionnaire The Body Sensations Questionnaire is a 17-item 5-point Likert scale that evaluates how afraid and anxious a patient is when he/she feels the physical sensation of each item in an unstable state 4 weeks
Secondary The Anxiety Sensitivity Index The Anxiety Sensitivity Index is a 16-item measure tapping the fear of anxiety sensations, which is known to be a risk factor for the development of panic. 4 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05868135 - Effects and Cost-effectiveness of e-Meistring - a Guided Internet-delivered Psychological Treatment
Active, not recruiting NCT05530642 - An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel N/A
Completed NCT02998502 - The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens N/A
Completed NCT01955954 - Using the Canary Breathing System for Panic Disorder Patients N/A
Completed NCT01963806 - ACT-smart: Smartphone-supplemented iCBT for Social Phobia and/or Panic Disorder N/A
Completed NCT01201967 - A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients Phase 4
Completed NCT00711737 - Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months N/A
Completed NCT00525226 - Evaluating the Effects of Stress in Pregnancy N/A
Completed NCT00605813 - Special Investigation Of Long Term Use Of Sertraline.
Completed NCT00353470 - Comparison of Psychotherapy Programs to Treat Panic Disorder Phase 3
Completed NCT00167479 - A Study of Risperidone Monotherapy in Bipolar Anxiety Phase 4
Completed NCT00540098 - Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder Phase 4
Completed NCT03233542 - The Association Between Physical Sensations and Thinking Styles N/A
Recruiting NCT05967468 - Evaluation of Family-Based Behavioral Treatments for Youth With Anxiety and Obsessive-Compulsive Disorder N/A
Completed NCT02811458 - Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders N/A
Active, not recruiting NCT05124639 - Clinical Trial of a Group Self-management Support Program for Anxiety Disorders N/A
Completed NCT04592536 - A Trial of the Effect of CVL-865 on Panic Symptoms Induced by Carbon Dioxide Inhalation in Healthy Subjects Phase 1
Completed NCT00025974 - Brain Chemical Receptor Effects in Patients With Panic Disorder and Post-Traumatic Stress Disorder N/A
Recruiting NCT02305537 - Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment N/A
Terminated NCT01680107 - D-cycloserine Augmented CBT for Panic Disorder Phase 3